RxDoctor Payments Data

Monica Sarawagi

Geriatric Medicine · Gering, NENPI 1689803686

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $368 and has fallen 93.8% since, to $23 in 2025. Among geriatric medicine clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$592in general payments, 2019–2025

Across 32 payments — averaging $18.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$106
  • Lilly USA, LLC$65
  • AstraZeneca$62
  • Sumitomo Pharma America, Inc.$51
  • Johnson & Johnson$50
  • Mylan Specialty L.p.$47
  • plus $211 from 10 others

What the payments were for

  • Food & beverage$592100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$592 in reported general payments places this provider in the 90th percentile of 21 geriatric medicine providers in Nebraska.

See all geriatric medicine providers in Nebraska

Medicare billing

Part B allowed, 2024
$43,810
Medicare patients
142
Services billed
546

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban32$31,445
EliquisApixaban21$27,738
JardianceEmpagliflozin22$17,984
Levothyroxine Sodium210$2,006
Rosuvastatin Calcium136$1,894
Sertraline Hcl33$1,614
Atorvastatin Calcium221$1,599
SynthroidLevothyroxine Sodium14$1,349
Losartan Potassium160$1,347
Lisinopril160$1,094
Metoprolol Succinate67$1,019
Ezetimibe40$956
Pantoprazole Sodium49$809
Omeprazole60$752
ValacyclovirValacyclovir Hcl15$653

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$50$31,44532 claims
PfizerEliquis$18$27,73821 claims
AbbVieSynthroid$23$1,34914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 21 geriatric medicine providers in Nebraska.

Other geriatric medicine in Gering

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →